IDEXX Laboratories Announces Second Quarter Results

Go back to IDEXX Laboratories Announces Second Quarter Results

IDEXX (IDXX) Oversold, Buy on Weakness - Stifel

August 1, 2017 12:31 PM EDT

Stifel analyst Jonathan Block sees shares of IDEXX Laboratories (NASDAQ: IDXX) as oversold and reiterated a Buy rating and price target of $185.

Block called the quarter "solid" with a raised outlook but notes shares are under pressure as the magnitude of the beat and... More